Calamos Advisors
XENE icon

Calamos Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

Calamos Advisors’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,637
Closed -$679K – 967
2023
Q2 		$679K Buy
+17,637
New +$679K ﹤0.01% 705